On Friday, Essa Pharma Inc (NASDAQ: EPIX) was -73.08% drop from the session before settling in for the closing price of $5.20. A 52-week range for EPIX has been $4.24 – $11.67.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at -13.00%. With a float of $43.38 million, this company’s outstanding shares have now reached $44.10 million.
In an organization with 50 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Essa Pharma Inc (EPIX) Insider Updates
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Essa Pharma Inc stocks. The insider ownership of Essa Pharma Inc is 2.22%, while institutional ownership is 79.97%. The most recent insider transaction that took place on Oct 07 ’24, was worth 4,185. In this transaction Chief Operating Officer of this company sold 694 shares at a rate of $6.03, taking the stock ownership to the 7,776 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Chief Operating Officer sold 694 for $6.00, making the entire transaction worth $4,164. This insider now owns 8,470 shares in total.
Essa Pharma Inc (EPIX) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -13.00% per share during the next fiscal year.
Essa Pharma Inc (NASDAQ: EPIX) Trading Performance Indicators
You can see what Essa Pharma Inc (EPIX) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 36.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.63, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.81 in one year’s time.
Technical Analysis of Essa Pharma Inc (EPIX)
Let’s dig in a bit further. During the last 5-days, its volume was 6.88 million. That was better than the volume of 0.25 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 21.87%. Additionally, its Average True Range was 0.72.
During the past 100 days, Essa Pharma Inc’s (EPIX) raw stochastic average was set at 0.00%, which indicates a significant increase from 0.00% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 532.82% in the past 14 days, which was higher than the 221.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.8698, while its 200-day Moving Average is $6.6424. However, in the short run, Essa Pharma Inc’s stock first resistance to watch stands at $1.5333. Second resistance stands at $1.6667. The third major resistance level sits at $1.7333. If the price goes on to break the first support level at $1.3333, it is likely to go to the next support level at $1.2667. Assuming the price breaks the second support level, the third support level stands at $1.1333.
Essa Pharma Inc (NASDAQ: EPIX) Key Stats
There are 44,369K outstanding shares of the company, which has a market capitalization of 16.72 million. As of now, sales total 0 K while income totals -26,580 K. Its latest quarter income was 0 K while its last quarter net income were -7,230 K.
